Huapont Life Science Co. Ltd. A | Cash Flow
Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
317
446
657
612
594
823
Depreciation, Depletion & Amortization
137
218
334
341
409
657
Other Funds
930
1,294
2,464
1,164
99
693
Funds from Operations
546
828
1,104
1,269
1,588
2,153
Changes in Working Capital
183
240
690
605
552
14
Net Operating Cash Flow
363
587
414
664
1,036
2,166
Capital Expenditures
380
586
832
651
968
Sale of Fixed Assets & Businesses
5
1
12
28
1,220
Purchase/Sale of Investments
851
2,046
284
2,465
87
Net Investing Cash Flow
1,047
2,816
723
3,147
87
Cash Dividends Paid - Total
-
-
226
407
305
Issuance/Reduction of Debt, Net
252
3,608
829
3,384
1,248
Net Financing Cash Flow
1,181
2,314
3,068
1,813
844
Net Change in Cash
460
79
2,844
618
1,845
Free Cash Flow
17
2
418
13
68
Deferred Taxes & Investment Tax Credit
3
60
46
41
104
21
Net Assets from Acquisitions
116
191
37
193
301
Other Sources
305
36
164
250
80
Exchange Rate Effect
38
7
85
52
121
Other Uses
11
30
314
117
32
About Huapont Life Science Co.
View Profile
